Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Anglogold Ashanti | AU | Nov 18, 2024 | 24.82 | +4.15 |
Anheuser-Busch InBev ADR | BUD | Nov 18, 2024 | 56.50 | +0.44 |
ANI Pharmaceuticals | ANIP | Nov 18, 2024 | 55.25 | -2.35 |
Anika Therapeutics | ANIK | Nov 18, 2024 | 17.04 | -1.22 |
Anixa Biosciences | ANIX | Nov 18, 2024 | 3.05 | -0.97 |
Annaly Capital Management | NLY | Nov 18, 2024 | 19.72 | +0.15 |
Annaly Capital Management F Pref | NLY-F | Nov 18, 2024 | 25.95 | +0.12 |
Annaly Capital Management G Pref | NLY-G | Nov 18, 2024 | 25.57 | +0.31 |
Annaly Capital Management I Pref | NLY-I | Nov 18, 2024 | 25.90 | +0.11 |
Annexon | ANNX | Nov 18, 2024 | 5.46 | -10.78 |
Annovis Bio | ANVS | Nov 18, 2024 | 6.82 | -0.29 |
ANSYS | ANSS | Nov 18, 2024 | 336.40 | +1.21 |
Antelope Enterprise | AEHL | Nov 18, 2024 | 0.28 | -7.66 |
Anterix | ATEX | Nov 18, 2024 | 33.07 | -1.61 |
Antero Midstream | AM | Nov 18, 2024 | 15.48 | +1.51 |
Antero Resources | AR | Nov 18, 2024 | 31.95 | +4.79 |
Anywhere Real Estate | HOUS | Nov 18, 2024 | 4.14 | +4.28 |
Aon | AON | Nov 18, 2024 | 380.51 | +0.32 |
APA | APA | Nov 18, 2024 | 22.46 | +0.36 |
Apartment Investment and Management | AIV | Nov 18, 2024 | 8.82 | +2.20 |
Apellis Pharmaceuticals | APLS | Nov 18, 2024 | 26.18 | -0.34 |
APi Group | APG | Nov 18, 2024 | 35.71 | +0.96 |
Apogee Enterprises | APOG | Nov 18, 2024 | 81.43 | -0.73 |
Apogee Therapeutics | APGE | Nov 18, 2024 | 45.33 | -4.06 |
Apollo Commercial Real Estate Finance | ARI | Nov 18, 2024 | 9.10 | +0.33 |
Apollo Global Management | APO | Nov 18, 2024 | 164.31 | +0.42 |
Apollomics A | APLM | Nov 18, 2024 | 0.19 | +102.09 |
AppFolio A | APPF | Nov 18, 2024 | 229.33 | -0.30 |
Appian A | APPN | Nov 18, 2024 | 36.54 | +0.30 |
Apple | AAPL | Nov 18, 2024 | 228.02 | +1.34 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.